Titelia

Fund shareholders of Armata Pharmaceuticals Inc

ISIN US04216R1023 · United States · LEI 549300QM1VCWH8KT0S21

Fund shareholders
11
Of which ETFs
1 10 other funds
Value held
5.4M $
Share of capital
1.4 % of 37.2M shares on Aug 6, 2026
FundSharesValueWeight in fundShare of capital
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS 238,4332.4M $0.00 %0.64 %as of Mar 31, 2026 ↗
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 113,5981.2M $0.00 %0.31 %as of Mar 31, 2026 ↗
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 58,264626.9K $0.00 %0.16 %as of Feb 28, 2026 ↗
Ultra-Small Company Market Fund Bridgeway Funds, Inc. 41,382423.8K $0.34 %0.11 %as of Mar 31, 2026 ↗
iShares Micro-Cap ETF iShares Trust 27,051277K $0.02 %0.07 %as of Mar 31, 2026 ↗
Fidelity Total Market Index Fund Fidelity Concord Street Trust 17,296186.1K $0.00 %0.05 %as of Feb 28, 2026 ↗
Fidelity Series Total Market Index Fund Fidelity Concord Street Trust 14,708158.3K $0.00 %0.04 %as of Feb 28, 2026 ↗
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS 7,18173.5K $0.00 %0.02 %as of Mar 31, 2026 ↗
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS 5,31654.4K $0.00 %0.01 %as of Mar 31, 2026 ↗
1290 VT Micro Cap Portfolio EQ Advisors Trust 1,97720.2K $0.01 %0.01 %as of Mar 31, 2026 ↗
Victory Extended Market Index Fund Victory Portfolios III 1,26312.6K $0.00 %0.00 %as of Apr 30, 2026 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
Ultra-Small Company Market Fund Bridgeway Funds, Inc. 0.34 %as of Mar 31, 2026 ↗
iShares Micro-Cap ETF iShares Trust 0.02 %as of Mar 31, 2026 ↗
1290 VT Micro Cap Portfolio EQ Advisors Trust 0.01 %as of Mar 31, 2026 ↗
Victory Extended Market Index Fund Victory Portfolios III 0.00 %as of Apr 30, 2026 ↗
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 0.00 %as of Feb 28, 2026 ↗
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 0.00 %as of Mar 31, 2026 ↗
Fidelity Series Total Market Index Fund Fidelity Concord Street Trust 0.00 %as of Feb 28, 2026 ↗
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS 0.00 %as of Mar 31, 2026 ↗
Fidelity Total Market Index Fund Fidelity Concord Street Trust 0.00 %as of Feb 28, 2026 ↗
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS 0.00 %as of Mar 31, 2026 ↗

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterShareholdersChangeSharesChange
2026Q211+1526,469+13.6 %
2026Q110+2463,308+14.4 %
2025Q480405,039-1.4 %
2025Q380410,652-0.1 %
2025Q280411,168-0.3 %
2025Q180412,425+1.7 %
2024Q480405,502+2.6 %
2024Q380395,077+6.7 %
2024Q28-1370,212+3.8 %
2024Q190356,513+1.1 %
2023Q49352,517

Institutional managers

42 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.

ManagerSharesValue
Madison Asset Management, LLC2,107,67521.6M $as of Mar 31, 2026
MILLENNIUM MANAGEMENT LLC257,9922.6M $as of Mar 31, 2026
683 Capital Management, LLC137,0001.4M $as of Mar 31, 2026
GEODE CAPITAL MANAGEMENT, LLC114,5551.2M $as of Mar 31, 2026
EDGEWOOD MANAGEMENT LLC100,0001M $as of Mar 31, 2026
Dauntless Investment Group, LLC90,580927.5K $as of Mar 31, 2026
SEI INVESTMENTS CO74,192759.7K $as of Mar 31, 2026
BlackRock, Inc.65,050666.1K $as of Mar 31, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLP64,759663.1K $as of Mar 31, 2026
Informed Momentum Co LLC60,955624.2K $as of Mar 31, 2026
GOLDMAN SACHS GROUP INC60,953624.2K $as of Mar 31, 2026
STATE STREET CORP50,800520.2K $as of Mar 31, 2026
BRIDGEWAY CAPITAL MANAGEMENT, LLC44,682457.5K $as of Mar 31, 2026
SeaCrest Wealth Management, LLC41,524425.2K $as of Mar 31, 2026
RENAISSANCE TECHNOLOGIES LLC38,496394.2K $as of Mar 31, 2026
Grey Ledge Advisors, LLC30,000307.2K $as of Mar 31, 2026
JANE STREET GROUP, LLC27,998286.7K $as of Mar 31, 2026
Qube Research & Technologies Ltd26,628272.7K $as of Mar 31, 2026
NORTHERN TRUST CORP24,646252.4K $as of Mar 31, 2026
Hudson Bay Capital Management LP17,584180.1K $as of Mar 31, 2026
CAPTRUST FINANCIAL ADVISORS13,140134.6K $as of Mar 31, 2026
BANK OF AMERICA CORP /DE/11,714120K $as of Mar 31, 2026
HRT FINANCIAL LP10,595108 $as of Mar 31, 2026
CITIGROUP INC5,16052.8K $as of Mar 31, 2026
UBS Group AG4,34944.5K $as of Mar 31, 2026

Declared shareholders of Armata Pharmaceuticals Inc

There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.

ShareholderDeclared stakeShares
Innoviva, Inc. and 1 other82.70 %55,467,459as of May 12, 2026 · SCHEDULE 13D
Cite this page

Titelia. "Fund shareholders of Armata Pharmaceuticals Inc". https://titelia.com/en/stocks/armata-pharmaceuticals-inc-US04216R1023